Shares of Victrex plc (LON:VCT - Get Free Report) fell 8.4% on Tuesday . The stock traded as low as GBX 667.62 ($9.07) and last traded at GBX 720 ($9.78). 827,259 shares traded hands during mid-day trading, an increase of 97% from the average session volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.68).
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on VCT. JPMorgan Chase & Co. lowered their target price on Victrex from GBX 940 ($12.77) to GBX 818 ($11.11) and set a "neutral" rating on the stock in a research note on Wednesday. Deutsche Bank Aktiengesellschaft downgraded Victrex to a "hold" rating and lowered their target price for the company from GBX 990 ($13.45) to GBX 850 ($11.55) in a research note on Tuesday.
View Our Latest Report on Victrex
Victrex Price Performance
The company has a 50 day simple moving average of GBX 795.78 and a 200 day simple moving average of GBX 890.75. The company has a quick ratio of 1.99, a current ratio of 4.39 and a debt-to-equity ratio of 10.93. The company has a market capitalization of £631.91 million, a price-to-earnings ratio of 20.58, a price-to-earnings-growth ratio of 1.92 and a beta of 0.69.
Victrex (LON:VCT - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) earnings per share for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. As a group, research analysts predict that Victrex plc will post 73.1078905 EPS for the current year.
Insider Transactions at Victrex
In other news, insider Dame Vivienne Cox bought 2,747 shares of Victrex stock in a transaction on Tuesday, July 8th. The shares were bought at an average price of GBX 721 ($9.79) per share, with a total value of £19,805.87 ($26,906.49). Also, insider David Thomas bought 1,158 shares of Victrex stock in a transaction on Tuesday, May 13th. The shares were purchased at an average cost of GBX 846 ($11.49) per share, for a total transaction of £9,796.68 ($13,308.90). Corporate insiders own 1.64% of the company's stock.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
